Skip to main content
Premium Trial:

Request an Annual Quote

Gene Codes Appeals District Court's Ruling in 9/11 Breach-of-Contract Suit

Premium

Gene Codes is appealing a US District Court Judge's ruling in a breach-of-contract suit it filed against the Office of the Chief Medical Examiner of New York late last year.

In June, a judge in the US District Court for the Southern District of New York denied Gene Codes' request for discovery, calling it "a fishing expedition," and granted the city's motion for summary judgment (BI 07/22/11).

In its suit, Gene Codes had alleged that the OCME misappropriated trade secrets related to DNA-matching software that it had developed to identify victims in the Sept. 11, 2001, terrorist attacks.

According to court documents dated July 28, the Ann Arbor, Mich.-based company has filed a Notice of Appeal in the United States Court of Appeals for the Second Circuit.

Further details of the appeal were not disclosed.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.